FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules.
Foschini F, Napolitano F, Servetto A, Marciano R, Mozzillo E, Carratù AC, Santaniello A, De Placido P, Cascetta P, Butturini G, Frigerio I, Regi P, Silvestris N, Delcuratolo S, Vasile E, Vivaldi C, Bianco C, De Placido S, Formisano L, Bianco R.
Foschini F, et al. Among authors: regi p.
Ther Adv Med Oncol. 2020 Sep 29;12:1758835920947970. doi: 10.1177/1758835920947970. eCollection 2020.
Ther Adv Med Oncol. 2020.
PMID: 33062062
Free PMC article.